학술논문

Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Document Type
Article
Source
Metabolites (2218-1989); Jan2024, Vol. 14 Issue 1, p40, 25p
Subject
CLINICAL trials
NON-alcoholic fatty liver disease
INDIVIDUALIZED medicine
INSULIN resistance
METABOLIC disorders
KIDNEYS
Language
ISSN
22181989
Abstract
Copyright of Metabolites (2218-1989) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)